Published in Proc Natl Acad Sci U S A on April 01, 1979
Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression. Proc Natl Acad Sci U S A (1988) 3.11
Nuclear proteins that bind the human gamma-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin. Mol Cell Biol (1988) 1.63
Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process. Proc Natl Acad Sci U S A (1982) 1.59
Regulation and expression of a growth arrest-specific gene (gas5) during growth, differentiation, and development. Mol Cell Biol (1992) 1.56
Protein kinase C activity and hexamethylenebisacetamide-induced erythroleukemia cell differentiation. Proc Natl Acad Sci U S A (1987) 1.34
Phorbol diesters stimulate the development of an early murine progenitor cell. The burst-forming unit-megakaryocyte. J Clin Invest (1985) 1.10
The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approach. Br J Cancer (1985) 1.10
Transcriptional regulation of a tumor promoter and mitogen-inducible gene in human lymphocytes. Mol Cell Biol (1984) 0.96
Antagonism between epidermal growth factor and phorbol ester tumor promoters in human breast cancer cells. J Clin Invest (1981) 0.93
Induced differentiation of erythroleukemia cells by hexamethylene bisacetamide: a model for cytodifferentiation of transformed cells. Environ Health Perspect (1989) 0.87
Inducer-mediated commitment of murine erythroleukemia cells to terminal cell division: the expression of commitment. Proc Natl Acad Sci U S A (1984) 0.87
Tumor promoters stimulate hyperplasia of microtubule organizing center and inhibit DNA synthesis in cultured cells. J Clin Invest (1984) 0.83
Tumor promoters enhance myeloid and erythroid colony formation by normal mouse hemopoietic cells. Proc Natl Acad Sci U S A (1980) 0.82
Continuous suppression of globin gene expression and differentiation of Friend erythroleukemia cells by phorbol 12-myristate 13-acetate (PMA) despite the loss of PMA binding sites by down regulation. Proc Natl Acad Sci U S A (1984) 0.80
Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proc Natl Acad Sci U S A (1971) 11.41
Erythroleukemic differentiation. Annu Rev Biochem (1978) 5.19
Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell (1975) 4.32
Globin messenger-RNA induction during erythroid differentiation of cultured leukemia cells. Proc Natl Acad Sci U S A (1972) 4.02
A new group of potent inducers of differentiation in murine erythroleukemia cells. Proc Natl Acad Sci U S A (1976) 3.70
Synthesis of mouse haemoglobin and globin mRNA in leukaemic cell cultures. Nat New Biol (1972) 3.50
The function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol (1974) 3.36
Commitment to erythroid differentiation by friend erythroleukemia cells: a stochastic analysis. Cell (1976) 2.88
Sequential induction of heme pathway enzymes during erythroid differentiation of mouse Friend leukemia virus-infected cells. J Exp Med (1976) 2.36
Tumor-promoting agents in two-stage carcinogenesis. Prog Exp Tumor Res (1969) 2.26
Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells. Cancer Res (1977) 2.26
Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture. Proc Natl Acad Sci U S A (1977) 2.09
Tumor promoters inhibit spontaneous differentiation of Friend erythroleukemia cells in culture. Proc Natl Acad Sci U S A (1977) 1.99
Effect of a tumour promoter on myogenesis. Nature (1977) 1.98
Inhibition of adipose conversion of 3T3 fibroblasts by tumour promoters. Nature (1977) 1.87
Hemoglobin biosynthesis in murine virus-induced leukemic cells in vitro: structure and amounts of globin chains produced. Blood (1972) 1.81
Transient inhibition of initiation of S-phase associated with dimethyl sulfoxide induction of murine erythroleukemia cells to erythroid differentiation. Proc Natl Acad Sci U S A (1977) 1.56
Accumulation of alpha- and beta-globin messenger RNAs in mouse erythroleukemia cells. Cell (1977) 1.54
Tumor promoters inhibit morphological differentiation in cultured mouse neuroblastoma cells. Science (1978) 1.39
A change in the stability of globin mRNA during the induction of murine erythroleukemia cells. Cell (1978) 1.37
Synthesis of erythrocyte-specific proteins in cultured friend leukemia cells. Cell (1975) 1.33
Induction of spectrin in erythroleukemic cells transformed by Friend virus. Proc Natl Acad Sci U S A (1977) 1.33
Effects of a tumor-promoting agent on chondrogenesis. Am J Anat (1977) 1.31
Surface changes in differentiating Friend erythroleukemic cells in culture. Cell (1977) 1.28
Globin messenger RNA synthesis and processing during haemoglobin induction in Friend cells. II. Evidence for post-transcriptional control in clone 707. Cell Differ (1974) 1.27
Differential effects of chemical inducers on expression of beta globin genes in murine erythroleukemia cells. Proc Natl Acad Sci U S A (1977) 1.25
Induction of delta-aminolevulinic acid synthetase during erythroid differentiation of cultured leukemia cells. Proc Soc Exp Biol Med (1974) 1.20
Heterogeneity of murine erythroleukemia cells with respect to tumor promoter-mediated inhibition of cell differentiation. Cancer Res (1978) 1.16
A re-evaluation of the concept of cocarciongenesis. Prog Exp Tumor Res (1969) 1.16
Induction of murine erythroleukemia differentiation by actinomycin D. Proc Natl Acad Sci U S A (1978) 1.15
Induction by ouabain of hemoglobin synthesis in cultured Friend erythroleukemic cells. Cell (1976) 1.13
Early and late volume changes during erythroid differentiation of cultured Friend leukemic cells. J Cell Physiol (1977) 1.11
Synthesis of globin mRNA in relation to the cell cycle during induced murine erythroleukemia differentiation. Proc Natl Acad Sci U S A (1978) 1.06
Lengthening of the G1 phase is not strictly correlated with differentiation in Friend erythroleukemia cells. Proc Natl Acad Sci U S A (1978) 1.02
Cell volume changes in relation to the cell cycle of differentiating erythroleukemic cells. Exp Cell Res (1978) 1.01
Changes in cyclic adenosine 3':5'-monophosphate levels during induction of differentiation in murine erythroleukemia cells. Cancer Res (1978) 0.99
Analysis of erythroid differentiation in Friend cells using noninducible variants. Cell (1978) 0.86
Hydrocortisone inhibits DMSO - induced differentiation of Friend erythroleukemia cells. Biochem Biophys Res Commun (1978) 0.82
Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer (2001) 9.12
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature (1999) 7.47
Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene (2007) 7.13
Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc Natl Acad Sci U S A (2000) 5.53
Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst (2000) 5.21
Erythroleukemic differentiation. Annu Rev Biochem (1978) 5.19
Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. Proc Natl Acad Sci U S A (2004) 3.86
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res (2000) 3.83
A new group of potent inducers of differentiation in murine erythroleukemia cells. Proc Natl Acad Sci U S A (1976) 3.70
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci U S A (1998) 3.62
In vitro synthesis of DNA components of human genes for globins. Nat New Biol (1972) 3.23
Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors. Proc Natl Acad Sci U S A (2005) 3.20
Histone deacetylase inhibitors as new cancer drugs. Curr Opin Oncol (2001) 2.91
Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. Proc Natl Acad Sci U S A (1996) 2.72
Induction of colony formation in vitro by human lymphocytes. Nature (1976) 2.71
Induction of erythroid differentiation in murine virus infected eythroleukemia cells by highly polar compounds. Proc Natl Acad Sci U S A (1975) 2.60
Increased efficiency of exogenous messenger RNA translation in a Krebs ascites cell lysate. Proc Natl Acad Sci U S A (1972) 2.49
Effects by heme, insulin, and serum albumin on heme and protein synthesis in chick embryo liver cells cultured in a chemically defined medium, and a spectrofluorometric assay for porphyrin composition. J Biol Chem (1975) 2.47
Erythropoietic differentiation in colonies of cells transformed by Friend virus. Proc Natl Acad Sci U S A (1974) 2.47
Sequential induction of heme pathway enzymes during erythroid differentiation of mouse Friend leukemia virus-infected cells. J Exp Med (1976) 2.36
Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1. EMBO J (2001) 2.32
Pyrazolo-triazoles as light activable DNA cleaving agents. Bioorg Med Chem (2000) 2.30
Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells. Cancer Res (1977) 2.26
Cloning and characterization of a histone deacetylase, HDAC9. Proc Natl Acad Sci U S A (2001) 2.19
Multiple biological activities of human recombinant interleukin 1. J Clin Invest (1986) 2.16
Induction of erythroid differentiation by dimethylsulfoxide in cells infected with Friend virus: relationship to the cell cycle. Proc Natl Acad Sci U S A (1975) 2.12
HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation. Proc Natl Acad Sci U S A (2008) 2.10
Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture. Proc Natl Acad Sci U S A (1977) 2.09
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells. Cancer Res (2001) 2.08
Decreased globin messenger RNA in thalassemia detected by molecular hybridization. Proc Natl Acad Sci U S A (1973) 2.07
Polyribosome dissociation and formation in intact reticulocytes with conservation of messenger ribonucleic acid. Proc Natl Acad Sci U S A (1965) 2.06
Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia. J Clin Invest (2001) 2.00
Erythroid cell differentiation: murine erythroleukemia cell variant with unique pattern of induction by polar compounds. Proc Natl Acad Sci U S A (1976) 1.99
Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell division. Proc Natl Acad Sci U S A (1986) 1.99
Positional cloning of the zebrafish sauternes gene: a model for congenital sideroblastic anaemia. Nat Genet (1998) 1.98
Relative numbers of human globin genes assayed with purified alpha and beta complementary human DNA. Proc Natl Acad Sci U S A (1975) 1.97
Abnormal or absent beta mRNA in betao Ferrara and gene deletion in delta beta thalassaemia. Nature (1976) 1.96
Purification and properties of bovine spleen heme oxygenase. Amino acid composition and sites of action of inhibitors of heme oxidation. J Biol Chem (1982) 1.83
Induction of aminolevulinate synthase and porphyrins in cultured liver cells maintained in chemically defined medium. Permissive effects of hormones on induction process. J Biol Chem (1977) 1.83
Induction of -aminolevulinic acid synthetase in chick embryo liver cells in cluture. Proc Natl Acad Sci U S A (1970) 1.77
Assays for porphyrins, delta-aminolevulinic-acid dehydratase, and porphyrinogen synthetase in microliter samples of whole blood: applications to metabolic defects involving the heme pathway. Proc Natl Acad Sci U S A (1972) 1.77
Murine erythroleukemia cell differentiation: DNase I hypersensitivity and DNA methylation near the globin genes. Proc Natl Acad Sci U S A (1982) 1.77
Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5. Proc Natl Acad Sci U S A (2000) 1.71
Prevention of cyclical attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone-releasing hormone. N Engl J Med (1984) 1.68
Globin composition and synthesis of hemoglobins in developing fetal mice erythroid cells. Science (1967) 1.66
Protein synthesis: its control in erythropoiesis. Science (1972) 1.65
A zebrafish model for hepatoerythropoietic porphyria. Nat Genet (1998) 1.62
Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process. Proc Natl Acad Sci U S A (1982) 1.59
Deficiency of acylpeptide hydrolase in small-cell lung carcinoma cell lines. J Lab Clin Med (1992) 1.58
Erythroid cell development in fetal mice: ultrastructural characteristics and hemoglobin synthesis. J Mol Biol (1967) 1.57
Porphyria cutanea tarda associated with the acquired immune deficiency syndrome. Am J Hematol (1987) 1.57
Transient inhibition of initiation of S-phase associated with dimethyl sulfoxide induction of murine erythroleukemia cells to erythroid differentiation. Proc Natl Acad Sci U S A (1977) 1.56
An ultrastructural study of early morphogenetic events during the establishment of fetal hepatic erythropoiesis. J Cell Biol (1969) 1.55
Accumulation of alpha- and beta-globin messenger RNAs in mouse erythroleukemia cells. Cell (1977) 1.54
Studies in lead poisoning. I. Microanalysis of erythrocyte protoporphyrin levels by spectrophotometry in the detection of chronic lead intoxication in the subclinical range. Biochem Med (1973) 1.53
Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process. Proc Natl Acad Sci U S A (1994) 1.52
Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma. Cancer Res (1999) 1.51
The effect of erythropoietin on colonial growth of erythroid precursor cells in vitro. Proc Natl Acad Sci U S A (1974) 1.51
Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacol Toxicol (1997) 1.50
Murine erythroleukemia cell differentiation: relationship of globin gene expression and of prolongation of G1 to inducer effects during G1/early S. Proc Natl Acad Sci U S A (1979) 1.50
Purification of erythropoietin-responsive cells by immune hemolysis. Proc Natl Acad Sci U S A (1972) 1.50
Purification and properties of uroporphyrinogen decarboxylase from human erythrocytes. A single enzyme catalyzing the four sequential decarboxylations of uroporphyrinogens I and III. J Biol Chem (1983) 1.50
Destruction of injured red cells in vivo. Am J Med (1966) 1.49
Delta-aminolevulinic acid dehydratase assay. Enzyme (1982) 1.49
A microassay for uroporphyrinogen I synthase, one of three abnormal enzyme activities in acute intermittent porphyria, and its application to the study of the genetics of this disease. Proc Natl Acad Sci U S A (1974) 1.48
Induction of apoptosis of human primary osteoclasts treated with a transcription factor decoy mimicking a promoter region of estrogen receptor alpha. Apoptosis (2005) 1.46
Gene expression in murine erythroleukemia cells. Transcriptional control and chromatin structure of the alpha 1-globin gene. J Mol Biol (1984) 1.46
Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent. Blood (1992) 1.46